Cited by 135T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmune cells in cancer

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model

Open access
Tadmor, Tamar, Zhang, Yu, Cho, Hyun-Mi, Podack, Eckhard R., Rosenblatt, Joseph D.·2011·Cancer Immunology, Immunotherapy

Abstract

Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affects expansion and function of T-regulatory cells ('T-regs') in a murine breast tumor model (EMT-6). We compared tumor growth, and the number and function of T-reg cells in wild-type immune-competent mice (ICM) and B-cell-deficient mice (BCDM). Mice were either tumor-naive or implanted with EMT-6 mammary adenocarcinoma cells. Tumor growth was markedly inhibited in BCDM, compared to wild-type mice (ICM). Increased T-reg expansion as defined by CD4+/CD25+/FOXP3+ cells was evident following EMT-6 inoculation in ICM in comparison with non-tumor-bearing mice or compared to BCDM in which tumor had been implanted. The percentage and absolute number of T-regs in the spleen, tumor draining lymph nodes, and tumor bed were significantly reduced in BCDM compared to ICM. T-reg function, measured by suppression and proliferation assays, was also reduced in tumor inoculated BCDM compared to ICM. Our studies indicate that absence of B cells may play a role in augmenting the T-cell anti-tumor response, in part due to effects on T-regulatory cell expansion and function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00262-011-0972-z

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Regulatory B cells can suppress antitumor immunity via the secretion of immunosuppressive cytokines, such as IL-10 and TGF-β, and the induction of Tregs.

    “Among various subtypes, regulatory B cells can suppress antitumor immunity via the secretion of immunosuppressive cytokines, such as IL-10 and TGF-β, and the induction of Tregs [42, 43].”

    From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [43]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 41 · Cited by 135

Authors
Tadmor, T., Zhang, Y., Cho, H.-M., Podack, E. R., & Rosenblatt, J. D.
Affiliations
  • Bnai Zion Medical Center (IL)
  • University of Miami (US)
Corresponding author
Rosenblatt, Joseph D.
Venue
Cancer Immunology, Immunotherapy
Published
2011-01-21
Volume
60
Issue
5
Pages
609-619
ISSN
  • 0340-7004 (ISSN-L)
  • 1432-0851
OpenAlex
W2116286718
Cited by
135
References
41
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 11 · 2018: 9 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 13 · 2013: 8 · 2012: 6
FWCI
4.38
Type
journal article
Language
en
Open access
Locations
  • Cancer Immunology Immunotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (P01CA109094, 5-P01-CA-109094-04)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
B cells, regulatory T cells, tumor immunosuppression, antitumor immunity, B cell deficiency, Foxp3, CD4+CD25+ T cells, tumor growth, tumor-draining lymph nodes, Treg suppressive function
MeSH terms
Animals, Antibodies, Monoclonal, B-Lymphocytes, Female, Flow Cytometry, Lymphocyte Depletion, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Neoplasm Transplantation, T-Lymphocytes, CD4 Antigens, Immunophenotyping, Mice, Knockout, Lymphocyte Count, Cell Line, Tumor, Cell Proliferation, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review